The physician obtained his bachelor's degree from Peking University Health Science Center and subsequently underwent rigorous surgical training at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, where he earned his Doctor of Surgery degree. During his training, he developed a strong interest in surgical oncology. He then completed a specialized fellowship in surgical oncology at Peking University Cancer Hospital. Currently, he serves as an Associate Chief Physician in the Second Ward of Hepatobiliary and Pancreatic Surgery/Retroperitoneal Soft Tissue Oncology, specializing in the diagnosis and surgical treatment of abdominal tumors, particularly hepatobiliary and pancreatic tumors, retroperitoneal tumors, and complex gastrointestinal tumors. He actively participates in multidisciplinary collaboration within his field. In recent years, he has contributed to projects such as the Beijing Municipal Science and Technology Commission's Research Special Project and the Hospital Authority's Peak Plan, and has published numerous academic papers in both domestic and international journals, summarizing experience while pursuing innovation. Patient-centered, he provides standardized, cutting-edge, and individualized diagnostic and therapeutic services, offering multiple treatment options to enrich patients' choices. Published Papers Articles from the Past 3 Years (in chronological order) • Xue G, Wang X, Liu B, et al. Surgical outcomes of major vascular resection for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis. J Cancer Res Clin Oncol. 2024 Jul 9;150(7):343. • Xue G, Wang Z, Liu B, et al. Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis. Int J Clin Oncol. 2024 Jul;29(7):1035-1043. • Qiu H, Wang Z, Liu B, et al. Surgical outcomes of locally advanced gastrointestinal stromal tumors after multivisceral resection: A retrospective study of 64 patients at a single institution. Intractable Rare Dis Res. 2024 Feb;13(1):51-56. • Wu J, Li C, Liu B, et al. Efficacy and safety of anlotinib plus camrelizumab in treating retroperitoneal soft tissue sarcomas: a single-center retrospective cohort study. Ann Transl Med. 2023 Mar 15;11(5):212. • Lv A, Liu BN, Liu DN, et al. Abdominoinguinal approach in en bloc resection of retroperitoneal sarcoma involving iliac vessels with graft interposition. Front Oncol. 2022 Dec 23;12:1040833. • Shi YJ #, Liu BN #, Li XT, et al. Establishment of a multi-parameters MRI model for predicting small lymph nodes metastases (<10 mm) in patients with resected pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2022 Sep;47(9):3217-3228. # Co-first authors • Li CP, Liu BN, Wu JH, et al. Contralateral internal iliac artery transposition for retroperitoneal sarcoma involving common iliac artery. Updates Surg. 2022 Jun;74(3):1157-1163. • Liu B, Wu J, Li C, et al. The role of coeliac axis resection in resected ductal adenocarcinoma of the distal pancreas: A result of tumour topography or a prognostic factor? Pancreatology. 2022 Jan;22(1):112-122.